Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0.
Chan C, Jansen JHM, Hendriks IST, van der Peet IC, Verdonschot MEL, Passchier EM, Tsioumpekou M, Nederend M, Klomp SA, Valerius T, Peipp M, Leusen JHW, Olofsen PA.
Chan C, et al. Among authors: passchier em.
Mol Cancer Ther. 2024 Sep 4;23(9):1317-1331. doi: 10.1158/1535-7163.MCT-24-0217.
Mol Cancer Ther. 2024.
PMID: 38958494